
Show Notes
Omicron variant
Dr Angelique Coetzee, South African Medical Association
First to raise alarm about the new omicron
https://www.youtube.com/watch?v=wr-v-bT8X38
a storm in a teacup
Why everyone up in arms
So far, what we have seen is very mild cases
17 to 18 November, noticed a change in clinical picture
After 10 week of low numbers
For not its extremely mild cases that we are seeing
Looking at the mildness of these symptoms, I think it’s been missed in other countries
Severely mild, headache
What is different is the extreme tiredness
Body aches
Mostly men under 40s
I really think the vaccine plays a role here, breakthrough infections, but very very mild
You can call all of the hospitals in Pretoria you will see there is not a huge influx of patients with this omicron
If Africa is not going to be vaccinated you will see new variants coming up
Rudo Mathivha, head of the intensive care unit at Soweto’s Baragwanath hospital
We’re seeing a marked change in the demographic profile of patients with Covid-19
Young people, in their 20s to just over their late 30s, are coming in with moderate to severe disease,
some needing intensive care.
About 65% are not vaccinated and most of the rest are only half-vaccinated
I’m worried that as the numbers go up, the public health care facilities will become overwhelmed
Urgent preparations are needed to enable public hospitals to cope with a potential large influx of patients needing intensive care
Omicron variant may be responsible for as many as 90% of the new SA cases
24% fully vaccinated
Omicron variant
50 mutations overall
32 on spike protein
10 on RBD (delta has 2 RBD mutations)
Presumed high viral load
Prof Ravi Gupta, University of Cambridge
https://www.bbc.co.uk/news/health-59418127
Beta was all immune escape and nothing else, Delta had infectivity and modest immune escape, this potentially has both to high degrees
US response
Already in US
NY, state of emergency
Africa travel restrictions from Monday
US citizens allowed back
TSA, 2.3 million passengers on Wednesday
Germany
https://www.dw.com/en/covid-germany-confirms-first-2-cases-of-omicron-variant/a-59958183
Two cases of omicron confirmed in Munich
Entered Munich airport on 24th November
Czech Republic
Confirms first omicron case in Liberec Woman had been in Namibia
Italy
One omicron infection coming from Mozambique.
Israel response
No entry to non Israelis
UK response
https://www.youtube.com/watch?v=CBMC6S7Hf1E
Brentwood in Essex and Nottingham, two cases linked
Thanks to SA for information
Spreads rapidly
Can be spread between people that are double vaccinated
Some immune escape
Need to slow down seeding
Time for vaccinations and boosters
More African countries added
Red list, 10-day hotel quarantine
PCR test by 2nd day in the country, isolate until then
All contacts of a detected case of omicron to self-isolate, regardless of vaccination status
Increase face coverings in public
Vaccines will give protection, boosters will help
Boost the booster campaign
Belgium, first Omicron variant case in Europe
Belgium, Health Minister Frank Vandenbroucke
B.1.1.529, found in an unvaccinated person
Who had developed symptoms and tested positive on Nov. 22.
Young adult woman, developed symptoms 11 days after returning from a trip to Egypt via Turkey.
Flu-like symptoms, but no signs of severe disease.
None of her household members developed symptoms, but were being tested.
Prof Sir Andrew Pollard, director of Oxford Vaccine Group
If you look at where most of the mutations are,
they are similar to regions of th Learn more about your ad choices. Visit megaphone.fm/adchoices
More from Dr. John Campbell
Lots of data available from https://c19hcq.org/meta.html Great talk with Professor Robert Clancy on his latest publication on this well known drug. Learn more about your ad choices. Visit megaphone.fm/adchoices
For young healthy adults, MODERNA SUBMITS AMENDMENT TO THE EMERGENCY USE AUTHORIZATION FOR AN ADDITIONAL BOOSTER DOSE OF ITS COVID-19 VACCINE IN THE U.S.Uploaded 22-03-22(Pfizer, 65 and older for 4th shot)https://twitter.com/moderna_tx/status/1504628697894113285https://investors.modernatx.com/news/news-details/2022/Moderna-Submits-Amendment-to-the-Emergency-Use-Authorization-for-an-Additional-Booster-Dose-of-its-COVID-19-Vaccine-in-the-U.S/default.aspxrequest to the U.S. Food and Drug Administration,for an amendment to the emergency use authorization,to allow for a fourth dose of its COVID-19 vaccine (mRNA-1273),in adults 18 years of age and older who,have received an initial booster of any of the authorized or approved COVID-19 vaccines. (A booster dose of the Modern, 50 µg authorized for emergency use in the U.S. under EUA for adults 18 years and older)Clinical trials are ongoing for Moderna's Omicron-specific booster (mRNA-1273.529),and a bivalent Omicron-specific booster (mRNA-1273.214).QuestionsWill the 4th shot increase antibodies?Is it an emergency for a healthy 18 year old to get a 4th dose of vaccine today?Can beneficial endpoints be demonstrated for the individual?What n would be needed to demonstrate these beneficial outcomes?Will the 4th shot reduce T cell immunity for internal viral proteins?If someone has had omicron infection, will a 4th dose increase beneficial outcomes further?Is it time to end emergency shortcuts and get back to RCTS?Will there be guarantees a 4th dose will not be mandated once emergency use authorization is granted?Full FDA Approval of a COVID-19 Vaccine: What You Should Knowhttps://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/full-fda-approval-of-a-covid-19-vaccine-what-you-should-knowThe approval system for vaccines uses scientific data and exacting standards,to ensure safe and effective vaccinesReview processes includeClinical trialsThe FDA requires rigorous testing of vaccines through a series of clinical trials,to make sure they work and are safe before authorizing or approving them for the public. The laboratories that conduct the trials are independent from the vaccine companies and the government, process is not biased.Risks and benefitsmust demonstrate that the benefits of a vaccine are greater than its risks for those who will be vaccinatedContinual monitoringthe FDA may pause the administration of vaccine to do more studies,and ensure that the problem does not outweigh the vaccine’s benefit.Manufacturing guidelinestest the vaccine doses in batches (lots),to ensure the quality and effectiveness of the vaccines remain consistent and reliable.UK 4th Jabhttps://www.telegraph.co.uk/news/2022/03/20/fourth-covid-jabs-rolled-five-million-vulnerable-people-starting/?li_source=LI&li_medium=liftigniter-onward-journeyFourth Covid jabs to be rolled out to about five million vulnerable people starting from next weekThe Joint Committee on Vaccinations and Immunisations (JCVI)https://www.gov.uk/government/news/jcvi-advises-a-spring-covid-19-vaccine-dose-for-the-most-vulnerableAnother dose of Pfizer or Moderna, (six months after third dose)care home residentsover-75simmunosuppressed people over 12 years Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
How to Prevent the Next Pandemic (Bill Gates)Uploaded 01-05-22If you would like John’s text books, (it is free to download the PDFs)http://159.69.48.3/by Bill Gates is published by Allen Lane at £25https://twitter.com/DrTedros/status/1515010722538954756https://www.dailymail.co.uk/news/article-10772223/Weve-not-seen-WORST-Covid-warns-Microsoft-billionaire-Bill-Gates.htmlhttps://www.telegraph.co.uk/books/what-to-read/bill-gatess-prevent-next-pandemic-triumph-systems-brain-feeling/It's not likely, I don't want to be a voice of doom and gloom, but it's way above a 5% risk that this pandemic, we haven't even seen the worst of itGlobal Epidemic Response and Mobilization initiativeShould be managed by the WHO,team of epidemiologists and computer modellers, dedicated, 2,000 to 3,000the only body capable, top-notch team of experts,$55bn a year globallystrengthening healthcare systems in low- and middle-income countrieseradication [of] whole families of respiratory disease, which would mean no more coronaviruses like Covid – and even better, no more flu https://www.wsj.com/articles/bill-gates-the-best-investment-ive-ever-made-11547683309https://www.gatesfoundation.org/ideas/articles/health-economist-global-health-financingWhat if we had invested $10 billion in energy projects in the developing world? In that case, the return would have been $150 billion. What about infrastructure? $170 billion. By investing in global health institutions, however, we exceeded all of those returns: The $10 billion that we gave to help provide vaccines, drugs, bed nets and other supplies in developing countries created an estimated $200 billion in social and economic benefits. Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial, Revelations of poor practices at a contract research companyhttps://www.bmj.com/content/375/bmj.n2635Uploaded 06-11-21Pfizer’s pivotal covid-19 vaccine trial, raise questions about data integrity and regulatory oversightThis was the original paperhttps://www.nejm.org/doi/full/10.1056/nejmoa2034577 Autumn 2020Pfizer’s chairman and chief executive, Albert BourlaAs I’ve said before, we are operating at the speed of scienceVentavia Research Grouphttps://www.ventaviaresearch.comResearchers were testing Pfizer’s vaccine at several sites in TexasA regional director, Brook Jackson has told The BMJ that the companyfalsified dataunblinded patientsemployed inadequately trained vaccinatorswas slow to follow up on adverse events reported in Pfizer’s pivotal phase III trialStaff who conducted quality control checks were overwhelmed by the volume of problems they were finding. US Food and Drug Administration (FDA) were informedVentavia fired her later the same day. The BMJ has been provided with dozens of internal company documents, photos, audio recordings, and emails.She repeatedly informed her superiorspoor laboratory managementpatient safety concernsdata integrity issuesthat drug assignment confirmation printouts were being left in participants’ charts, accessible to blinded personnel (later corrected)company wasn’t able to quantify the types and number of errors they were finding when examining the trial paperwork for quality controlICON, the contract research organisationhttps://www.iconplc.com/services/clinical-research-services/data-management/?creative=528047015643&keyword=small%20clinical%20research%20organizations&matchtype=b&network=g&device=c&campaignid=6471798703&adgroupid=124362508020&feeditemid=54055202224&adposition=&gclid=CjwKCAjwz5iMBhAEEiwAMEAwGB-tlgJ18Rir0V_YfW6YdQNvt33JmuRwwwZiAkL22Zh99BWJbYLb2xoCWKUQAvD_BwEICON then highlighted over 100 outstanding queries older than three daysWorries over FDA inspectionConcerns raisedParticipants placed in a hallway after injection and not being monitored by clinical staffLack of timely follow-up of patients who experienced adverse eventsProtocol deviations not being reportedVaccines not being stored at proper temperaturesMislabelled laboratory specimensTargeting of Ventavia staff for reporting these types of problems.FDA advisory committee meeting held on 10 December 2020Problems at Ventavia not mentionedThe next day the FDA issued the authorisation of the vaccine In August this year, after full FDA approval of Pfizer’s vaccineFDA published that 9 of the trials 153 sites were inspectedFDA, full trial swabs were not taken from 477 people with suspected cases of symptomatic covid-19Other employees’ accountseverything that you complained about was spot onTwo former Ventavia employees spoke to The BMJ anonymously for fear of reprisal and loss of job prospects in the tightly knit research communityI don’t think it was good clean dataIt’s a crazy messPfizer has hired Ventavia as a research subcontractor on four other vaccine clinical trialscovid-19 vaccine in children and young adultspregnant womena booster dosean RSV vaccine trialNCT04816643, NCT04754594, NCT04955626, NCT05035212). Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
Discussion about multicultural aspect of health care.Uploaded 01-10-23The Liger, Rex Soderlundhttps://theliger.substack.com/p/understanding-ecological-technologyWefwafwa’s channelhttps://www.youtube.com/@WefwafwaAndrew Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices